Orin
CBOENYSE·Financial - Data & Stock Exchanges

Cboe Global Markets, Inc. CBOE

Market cap $28.2BP/E 20.9× trailingGross margin 52.3%Reports Fri 30 Oct, before the open
$268.87
+2.04 (+0.76%)Wed close 16:00 ET
52-wk $227.15 – $371.18
Watch
Orin's take
0.62conviction · moderate
Refreshed 30 Aug · take v8. A new filing or a print queues the next refresh.

CBOE's FY2025 results are genuinely strong — revenue grew 15.1% to $4.71B, diluted EPS jumped 44.5% to $10.42, and free cash flow of $1.15B funded a 19% dividend hike to $0.86 quarterly (16th consecutive increase) — but the stock has already rebounded from its 22% drawdown to $310.45, trading at 24.1x P/E, a 94% premium to the peer median of 12.4x. Smart money flows turned slightly negative at -0.0144 as of Q2 2026 with fund count declining from 63 to 60, and insiders remain net sellers on a value basis (-$1.65M over 24 months), suggesting the recovery has outpaced conviction from those closest to the business.

The growth story is real but largely priced into the premium multiple, leaving balanced risk/reward at current levels.

What could go wrong

  • Regulatory friction. Kalshi petitioned the SEC to slow Cboe product launches (Aug 25, 2026), signaling rising competitive and regulatory headwinds in prediction markets and new product innovation.
  • Valuation premium. P/E of 24.1x is 94% above the peer median of 12.4x and P/S of 6.4x is 189% above the 2.2x median, leaving little margin for any growth disappointment.
  • Smart money outflows. Smart money score deteriorated from +0.0396 in mid-2025 to -0.0144 as of Q2 2026, with fund count falling from 63 to 60, indicating institutional positioning is softening.
  • Insider selling. Over the trailing 24 months insiders net sold $1.65M in value despite net positive share count from RSU grants; recent open-market sales include Froetscher selling at $358.09 in May and $278.95 in August 2026.

What would change my mind

Q3 2026 earnings acceleration. Revenue growth sustains above 15% YoY with operating margin holding above 32%, confirming the FY2025 momentum is continuing into 2026bullish
Smart money reversal. Smart money score turns meaningfully positive (>+0.02) with fund count increasing in the next 13F filing, signaling institutional repositioningbullish
SEC product delay. SEC acts on Kalshi's petition or imposes restrictions on Cboe's new product pipeline, dampening the growth narrative that supports the premium multiplebearish
Margin compression. Operating margin declines below 30% in upcoming quarterly results, indicating the FY2025 margin expansion to 32.1% is not sustainablebearish

Where this comes from: FMP annual fundamentals FY2025 · derived_metrics FY2025 · peer_relative composite · PRNewsWire 2026-08-13. Orin's read on CBOE; not advice.

Twelve months actual closes to 2026-09-23 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Vanguard Capital Management$1.7B0.0% of fund
Vanguard Portfolio Management$1.3B0.1% of fund
State Street$1.2B0.0% of fund
Alliancebernstein L.P$1.1B0.4% of fund
Fmr$1.0B0.0% of fund
Geode Capital Management$755.2M0.0% of fund

91 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 187 Form 4 filings, net −$1.7M. Of the 50 on hand, 0 were open-market purchases and 3 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about CBOE

its filings · its transcripts · its numbers

Orin answers questions about CBOE from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days

Where it trades

vs its own 5y · Financial Services
MetricNowOwn medianSector
P/E20.9×26.4×21.6×
EV/EBITDA13.4×15.7×
P/S5.56×5.01×
P/B5.0×4.7×

Its P/E sits below all 5 of the last 5 years (−0.86σ from its own mean).

What the price assumes

10.4%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $1.2B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

31 firms · 2026-09-23
Consensus target

$317

$258$356 · +18% against today's price

How they rate it
  • 14 buy or overweight
  • 13 hold
  • 4 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 11.3× of 3 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
CBOECboe Global Markets, Inc.$28B20.9×13.4×52.3%26.7%26%
CINFCincinnati Financial Corporation$25B7.6×5.5×52.3%23.8%21%
HBANHuntington Bancshares Incorporated$31B11.3×14.2×63.7%16.6%9%
USBU.S. Bancorp$91B11.7×11.1×63.8%18.7%12%

The median is of the 3 peers listed above and nothing else — check it against the column. This company trades 84.7% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY14 28.7×FY25 24.0×

What its sector has traded at

Financial Services
FY14 29.6×FY26 23.9×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$282$295.67 · −5%2026-06-10
Levered DCF$319$295.67 · +8%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $268.87
52-week range$227 – $371
Analyst targets$258 – $356
Standard DCF$282 as of 2026-06-10, when it was $295.67
Levered DCF$319 as of 2026-06-10, when it was $295.67
At own 5y-median P/E (26×)$339
At 5y P/E range (24–57×)$307 – $730
At sector P/E (22×)$277

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.